These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 23536610)

  • 1. Myocardial reperfusion injury: looking beyond primary PCI.
    Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
    Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Role of mPTP in Ischemia-Reperfusion Injury.
    Morciano G; Bonora M; Campo G; Aquila G; Rizzo P; Giorgi C; Wieckowski MR; Pinton P
    Adv Exp Med Biol; 2017; 982():169-189. PubMed ID: 28551787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing myocardial infarct size: challenges and future opportunities.
    Bulluck H; Yellon DM; Hausenloy DJ
    Heart; 2016 Mar; 102(5):341-8. PubMed ID: 26674987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.
    Heusch G; Gersh BJ
    Eur Heart J; 2017 Mar; 38(11):774-784. PubMed ID: 27354052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioning the heart to prevent myocardial reperfusion injury during PPCI.
    Hausenloy DJ
    Eur Heart J Acute Cardiovasc Care; 2012 Apr; 1(1):13-32. PubMed ID: 24062884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
    He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
    Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial ischemia-reperfusion injury: a neglected therapeutic target.
    Hausenloy DJ; Yellon DM
    J Clin Invest; 2013 Jan; 123(1):92-100. PubMed ID: 23281415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Reiter RJ
    World J Cardiol; 2014 Mar; 6(3):100-6. PubMed ID: 24669291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
    Rossello X; Lobo-Gonzalez M; Ibanez B
    Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury.
    Ong SB; Samangouei P; Kalkhoran SB; Hausenloy DJ
    J Mol Cell Cardiol; 2015 Jan; 78():23-34. PubMed ID: 25446182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI.
    Ndrepepa G
    Coron Artery Dis; 2015 Jun; 26(4):341-55. PubMed ID: 25715338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.
    Li J; Sun D; Li Y
    Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?
    Lønborg JT
    Heart; 2015 Oct; 101(20):1612-8. PubMed ID: 26130664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A single-center cross-sectional study.
    Mukherjee P; Jain M
    Ann Card Anaesth; 2019; 22(4):347-352. PubMed ID: 31621667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection by combined intrahospital remote ischaemic perconditioning and postconditioning in ST-elevation myocardial infarction: the randomized LIPSIA CONDITIONING trial.
    Eitel I; Stiermaier T; Rommel KP; Fuernau G; Sandri M; Mangner N; Linke A; Erbs S; Lurz P; Boudriot E; Mende M; Desch S; Schuler G; Thiele H
    Eur Heart J; 2015 Nov; 36(44):3049-57. PubMed ID: 26385956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.
    Montecucco F; Carbone F; Schindler TH
    Eur Heart J; 2016 Apr; 37(16):1268-83. PubMed ID: 26543047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction.
    Bellis A; Mauro C; Barbato E; Di Gioia G; Sorriento D; Trimarco B; Morisco C
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967374
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.